About this trial
Eating disorders (EDBs) are mental disorders with a great impact on the lives of individuals as well as a great cost imposed on society. The treatments currently available rely on different forms of psychotherapies with an unsatisfactory response rate as well as a considerable relapse rate . One of the reasons underlying the low success of available therapeutic modalities would be the heterogeneity of the clinical presentation of EDs, making their classification and the personalization of their treatment more difficult.The investigators hypothesize that a secondarily dimensional classification approach (respecting the categorical classification currently in use) of EDs based on the different dimensions disturbed in these disorders as well as in their comorbidities, would better represent their nosographic reality, which could provide patients with more personalized and potentially more effective care.
Eligibility criteria
Qualifiers
Patient with an eating disorder according to DSM-V criteria
Patient aged from 15 to 65 years
Patient who performs the day-hospital evaluation
Patient affiliated to a French social security system
Disqualifiers
Patient in an unstable somatic state (eg severe metabolic disorder making impossible or unreliable neuropsychological assessments)
Patient's refusal to participate
Patient protected by law (guardianship or curatorship)*
Pregnant or nursing women. A dosage of βHCG will be performed to ensure the absence of pregnancy
Trial design
Treatments tested in this trial
- Ambulatory cares in a day-hospital (Lapeyronie, Montpellier) specialized in the evaluation of eating disorders.